Provider of human and animal biospecimens, AMS Bio, now offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository.
To support increasingly complex research, the company aims to provide a full range of blood-based products, including whole blood, serum, plasma, blood and peripheral blood mononuclear cells (PBMCs). All samples are collected under IRB approval by certified phlebotomists and processed by standard operating procedures.
Drawing upon a well-established and extensive network, AMS Bio offers custom collections according to donor demographics, sample volume and processing method. Covering many therapeutic areas including oncology, autoimmune, and neurodegenerative disease, samples can be delivered from patient cohorts that precisely match the unique requirements of different research studies.
The company also offers a custom collection service, allowing acquisition of healthy, common and rare diseased tissue samples according to unique research requirements. These tissue samples can be tailored to specific donor demographic requests, tissue processing protocols, or matched sample set criteria. These tissues can be prepared in the format best suited to the research including FFPE, fresh frozen, or frozen OCT blocks. All tissue specimens are collected under ethical regulations and in accordance with all applicable local and international laws. The firm is able to identify mutation specific SNPs, fusions and rearrangements, and perform next-generation sequencing analyses on your tumour tissues of interest and identify over-expression.
